CARCINOMA, SQUAMOUS CELL
Clinical trials for CARCINOMA, SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized mRNA cancer vaccine trial halted midway
Disease control TerminatedThis study tested a personalized mRNA vaccine (mRNA-4157) combined with the immunotherapy drug pembrolizumab for people with advanced but removable skin cancer (cutaneous squamous cell carcinoma). The goal was to see if the combination could prevent the cancer from coming back be…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Lung cancer biomarker study halted after enrolling only 22 patients
Knowledge-focused TerminatedThis study aimed to find genetic changes in lung tissue and blood that could predict how squamous cell lung cancer progresses. Researchers planned to collect samples from 200 patients undergoing lung procedures, but the study was stopped early with only 22 participants. No treatm…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC